when was tirzepatide approved https://investor.lilly.com/news-releases/news-release-details/zepbound- tirzepatide-most-prescribed-weight-management “Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) a label expansion for Zepbound Lilly Rises on FDA Approval

Users reported both positive effects, such as increased skin pigmentation and improved libido, and negative side effects, including nausea, facial flushing, and spontaneous erections

Yet, several cases of skin irritation, allergic contact dermatitis, and eczema have been reported with the use of dexpanthenol-containing ointments (45-49)

By targeting two appetite-regulating hormones instead of one, Mounjaro may lead to more significant weight loss than GLP-1 medications alone

And they're getting it online

Lee, A.-Y., Kim, N.-H., Choi, W.-I

These changes are subtle in the first weeks and more noticeable by the end of the first cycle